Detection of COVID-19 in Saliva Collection
- Conditions
- Saliva CollectionRT-PCRNasopharyngeal SampleSars-CoV2
- Registration Number
- NCT04386551
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample.
Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 501
- patient hospitalized at the Amiens CHU in a COVID-19 unit
- patient seen as outpatient in the area of infectious pathologies for COVID-19 infection
- Patients under 18
- patients under guardianship or curators
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of SARS-CoV-2 RNA in the saliva sample day 1 Detection of SARS-CoV-2 RNA in the saliva sample
Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results day 1 Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Amiens
🇫🇷Amiens, France